← All trials
NCT01908283
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 1, 2014
- Primary completion
- Jun 1, 2016
- Completion date
- Dec 1, 2016
- First posted
- —
- Last posted
- —
- Enrollment
- 300
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- University of GenevaLead sponsor
- University of GenevaOverall official - principal investigator
- University of GenevaSponsor investigator
- Swiss IBD Cohort StudyCollaborator
- Schweizerische Morbus Crohnund Colitis ulcerosa VereinigungCollaborator
- Foundation for liver and gut studiesCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.